NDUFS5 | NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) | Mitochondrial proteins
| | | | | Expressed in all |
PABPC4 | Poly(A) binding protein, cytoplasmic 4 (inducible form) | | | | | | Expressed in all |
CTPS1 | CTP synthase 1 | Enzymes
| | | | | Expressed in all |
YBX1 | Y box binding protein 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ELOVL1 | ELOVL fatty acid elongase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
KIF2C | Kinesin family member 2C | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
UROD | Uroporphyrinogen decarboxylase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
MMACHC | Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria | Disease related genes
| | | | | Mixed |
PRDX1 | Peroxiredoxin 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
NASP | Nuclear autoantigenic sperm protein (histone-binding) | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GPBP1L1 | GC-rich promoter binding protein 1-like 1 | | | | | | Expressed in all |
NRD1 | Nardilysin (N-arginine dibasic convertase) | Enzymes Plasma proteins
| | | | | Expressed in all |
RAB3B | RAB3B, member RAS oncogene family | | | | | | Tissue enhanced |
ZFYVE9 | Zinc finger, FYVE domain containing 9 | | | | | | Mixed |
CPT2 | Carnitine palmitoyltransferase 2 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
MAGOH | Mago-nashi homolog, proliferation-associated (Drosophila) | Transporters
| | | | | Expressed in all |
MRPL37 | Mitochondrial ribosomal protein L37 | Mitochondrial proteins Ribosomal proteins
| | | | | Expressed in all |
JUN | Jun proto-oncogene | Cancer-related genes FDA approved drug targets Transcription factors
| | | | | Expressed in all |
NFIA | Nuclear factor I/A | Transcription factors
| | | | | Expressed in all |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MIER1 | Mesoderm induction early response 1, transcriptional regulator | Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
SERBP1 | SERPINE1 mRNA binding protein 1 | Plasma proteins
| | | | | Expressed in all |
LRRC40 | Leucine rich repeat containing 40 | | | | | | Expressed in all |
SRSF11 | Serine/arginine-rich splicing factor 11 | Plasma proteins
| | | | | Expressed in all |
ANKRD13C | Ankyrin repeat domain 13C | | | | | | Expressed in all |
CRYZ | Crystallin, zeta (quinone reductase) | Enzymes Plasma proteins
| | | | | Expressed in all |
RABGGTB | Rab geranylgeranyltransferase, beta subunit | Enzymes
| | | | | Expressed in all |
FAM73A | Family with sequence similarity 73, member A | Predicted membrane proteins
| | | | | Expressed in all |
FUBP1 | Far upstream element (FUSE) binding protein 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
DDAH1 | Dimethylarginine dimethylaminohydrolase 1 | Enzymes Plasma proteins
| | | | | Mixed |
SH3GLB1 | SH3-domain GRB2-like endophilin B1 | Mitochondrial proteins
| | | | | Expressed in all |
CCBL2 | Cysteine conjugate-beta lyase 2 | Enzymes
| | | | | Expressed in all |
GBP1 | Guanylate binding protein 1, interferon-inducible | Plasma proteins
| | | | | Expressed in all |
ZNF326 | Zinc finger protein 326 | | | | | | Expressed in all |
CDC7 | Cell division cycle 7 | Enzymes Plasma proteins
| | | | | Mixed |
GLMN | Glomulin, FKBP associated protein | Disease related genes
| | | | | Expressed in all |
DR1 | Down-regulator of transcription 1, TBP-binding (negative cofactor 2) | | | | | | Expressed in all |
GCLM | Glutamate-cysteine ligase, modifier subunit | Cancer-related genes
| | | | | Expressed in all |
CNN3 | Calponin 3, acidic | Plasma proteins
| | | | | Expressed in all |
DBT | Dihydrolipoamide branched chain transacylase E2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
SARS | Seryl-tRNA synthetase | Enzymes Plasma proteins
| | | | | Expressed in all |
SORT1 | Sortilin 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
PSMA5 | Proteasome (prosome, macropain) subunit, alpha type, 5 | Enzymes Plasma proteins
| | | | | Expressed in all |
CYB561D1 | Cytochrome b561 family, member D1 | Predicted membrane proteins
| | | | | Mixed |
GSTM3 | Glutathione S-transferase mu 3 (brain) | Cancer-related genes Enzymes
| | | | | Expressed in all |
VANGL1 | VANGL planar cell polarity protein 1 | Disease related genes Predicted membrane proteins
| | | | | Mixed |
PTGFRN | Prostaglandin F2 receptor inhibitor | CD markers Predicted membrane proteins
| | | | | Mixed |
PHGDH | Phosphoglycerate dehydrogenase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |